Clinical Trial Update: Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT [Phase 3]

View source ↗

Summary

A Phase III randomized trial comparing radiotherapy plus toripalimab against sorafenib in advanced hepatocellular carcinoma with portal vein tumor thrombosis ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Radiotherapy, Toripalimab | Phase 3 | Status: TERMINATED